GlassScriptPhysician profile
Robert M Feldman
NPI 1093796864
$30,589.85
in general payments reported to CMS, 2019-2025
18 companies · $794 in 2025
The $794 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,374 · 2020: $3,561 · 2021: $163 · 2022: $1,492 · 2023: $9,333 · 2024: $12K · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $4,268 · Food and Beverage: $3,383 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,310.00 |
| Travel and Lodging | $4,268.26 |
| Food and Beverage | $3,382.75 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $19,933.87 | 2022-2025 | Hydrus Microstent, Rocklatan, Rhopressa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $4,556.33 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $1,953.57 | 2022-2023 | Iolmaster 700, Forum, Humphrey Field Analyzer (Hfa3) |
| New World Medical,INC. | $1,898.90 | 2019 | |
| Glaukos Corporation | $441.62 | 2024-2025 | Idosetr, Radius |
| Heidelberg Engineering, INC. | $354.19 | 2024-2025 | Spectralis |
| Abbvie INC. | $242.79 | 2023-2025 | |
| Mobius Therapeutics, LLC | $200.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $191.32 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $187.43 | 2022-2023 | Miebo, Vyzulta |
| Rxsight INC | $151.49 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Ivantis, INC | $131.88 | 2019 | |
| Carl Zeiss Meditec, INC. | $88.49 | 2021-2023 | Cirrus Hd-Oct |
| Tarsus Pharmaceuticals, INC. | $83.74 | 2024 | Xdemvy |
| Alcon Puerto Rico INC | $69.89 | 2023 | Clareon |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $60.72 | 2020 | |
| Sight Sciences, INC. | $43.62 | 2023 | Sion Surgical Instrument, Omni Surgical System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.